Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats
- 1 March 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 232 (2-3), 147-158
- https://doi.org/10.1016/0014-2999(93)90768-d
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ucb L059, a novel anti-convulsant drug: pharmacological profile in animaisEuropean Journal of Pharmacology, 1992
- Nootropic Drugs Positively Modulate α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid‐Sensitive Glutamate Receptors in Neuronal CulturesJournal of Neurochemistry, 1992
- The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indicesEpilepsy Research, 1991
- The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure modelsEpilepsy Research, 1991
- The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehiclesEpilepsy Research, 1990
- Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling modelEuropean Journal of Pharmacology, 1989
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988
- Anticonvulsant efficacy of clonazepam and the β-carboline ZK 93423 during chronic treatment in amygdala-kindled ratsEuropean Journal of Pharmacology, 1987
- Comparative assay of anticonvulsant and toxic potencies of sixteen GABAmimetic drugsNeuropharmacology, 1982
- The effect of interstimulation interval on the assessment and stability of kindled seizure thresholdsBrain Research Bulletin, 1981